Becoming a physician enables you to help patients and make a difference in their lives, not just by providing high quality health care, but also by being a researcher, educator and an advocate.
A talented surgical oncologist and scientist, Mustafa Raoof, M.D., M.S., joined City of Hope in 2015, where he focuses on the surgical treatment of cancers within the abdominal cavity, particularly those from the liver, bile ducts, pancreas and the gastrointestinal tract. Additionally, Dr. Raoof has expertise in treating cancers that have spread to involve the liver or the peritoneum.
At City of Hope, Dr. Raoof is part of one of the largest programs in the region performing complex cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for cancers that have disseminated within the abdominal cavity. He also has vast experience in providing all aspects of surgical care to patients whose cancer has spread to the liver.
In addition to clinical practice, Dr. Raoof conducts laboratory research focusing on DNA repair mechanisms in cancers. He is particularly interested in pancreatic cancer that has been very challenging to treat. By identifying and characterizing DNA repair processes that help cancer cells escape the toxic effects of chemotherapy, he is working to develop better targets for future therapies.
Dr. Raoof received his medical degree from Pakistan's Aga Khan University, then came to the U.S. where he continued his training at Harvard University, Yale University, MD Anderson Cancer Center and University of Arizona. He is the author of dozens of peer-reviewed papers that have been published in leading scientific journals, including Nature, Journal of National Cancer Institute and Biomaterials. Dr. Raoof is the recipient of several honors and awards, most notably, the National Comprehensive Cancer Network's Young Investigator Award, and the Pancreatic Cancer Action Network's Career Development Award.
Dr. Raoof’s mission is to deliver complex surgical oncology care with expertise and compassion, as well as to develop new therapies for patients with gastrointestinal cancers. To that end, he chose City of Hope for its “culture of scientific discovery that accelerates adaptation of groundbreaking treatments to clinical cancer care.”